L
084650
vs
K
KOSPI 200
Over the past 12 months, Labgenomics Co Ltd has underperformed KOSPI 200, delivering a return of -75% compared to KOSPI 200's +152% growth.
Stocks Performance
084650 vs KOSPI 200
Performance Gap
084650 vs KOSPI 200
Performance By Year
084650 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Labgenomics Co Ltd
Glance View
Labgenomics Co Ltd makes molecular diagnostic products, especially test kits that detect DNA or RNA from infectious diseases and other medical conditions. It sells these kits to hospitals, clinical laboratories, and distributors that need laboratory tests they can run on patient samples. The company’s business is built around turning lab science into practical diagnostic tools that can be used in everyday medical testing. Most of its money comes from selling diagnostic kits and related products, either directly to end users or through distribution partners. In this kind of business, the company earns repeat sales when labs keep ordering consumables and test kits, rather than from one-time equipment sales alone. That gives Labgenomics a place in the medical testing supply chain as a specialist product maker. What makes the company’s role distinct is that it sits between medical research and routine care: it develops tests, gets them into a format labs can use, and supplies them to customers that need reliable results quickly. Its value depends on the accuracy, ease of use, and regulatory acceptance of its tests, which are central concerns in the diagnostics industry.
